Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$0.53 - $0.93 $45,825 - $80,410
86,463 Added 7.57%
1,228,810 $712,000
Q3 2023

Oct 31, 2023

SELL
$1.12 - $1.88 $2,755 - $4,624
-2,460 Reduced 0.21%
1,142,347 $1.29 Million
Q2 2023

Aug 11, 2023

SELL
$1.31 - $2.04 $479,529 - $746,748
-366,053 Reduced 24.23%
1,144,807 $1.83 Million
Q1 2023

May 11, 2023

BUY
$1.45 - $2.95 $552,548 - $1.12 Million
381,068 Added 33.73%
1,510,860 $2.3 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $441,848 - $710,895
218,737 Added 24.01%
1,129,792 $2.71 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $1.53 Million - $2.45 Million
779,286 Added 591.4%
911,055 $1.87 Million
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $799,493 - $1.62 Million
-614,995 Reduced 82.35%
131,769 $256,000
Q1 2022

May 12, 2022

BUY
$2.35 - $3.47 $1.07 Million - $1.58 Million
456,594 Added 157.35%
746,764 $1.84 Million
Q4 2021

Feb 10, 2022

SELL
$2.92 - $5.74 $1.86 Million - $3.66 Million
-636,927 Reduced 68.7%
290,170 $934,000
Q3 2021

Nov 10, 2021

BUY
$4.98 - $6.63 $825,439 - $1.1 Million
165,751 Added 21.77%
927,097 $4.87 Million
Q2 2021

Aug 11, 2021

BUY
$2.56 - $5.49 $58,181 - $124,771
22,727 Added 3.08%
761,346 $4.18 Million
Q1 2021

May 12, 2021

BUY
$2.69 - $5.25 $31,760 - $61,986
11,807 Added 1.62%
738,619 $2.01 Million
Q4 2020

Feb 10, 2021

BUY
$3.17 - $4.49 $22,002 - $31,165
6,941 Added 0.96%
726,812 $2.31 Million
Q3 2020

Nov 13, 2020

SELL
$2.98 - $5.2 $57,785 - $100,833
-19,391 Reduced 2.62%
719,871 $2.88 Million
Q2 2020

Aug 12, 2020

BUY
$2.29 - $4.24 $198,705 - $367,909
86,771 Added 13.3%
739,262 $2.91 Million
Q1 2020

May 14, 2020

SELL
$1.92 - $4.39 $560,248 - $1.28 Million
-291,796 Reduced 30.9%
652,491 $1.6 Million
Q4 2019

Feb 12, 2020

BUY
$2.41 - $4.4 $358,829 - $655,124
148,892 Added 18.72%
944,287 $3.84 Million
Q3 2019

Nov 12, 2019

BUY
$2.17 - $3.14 $1.69 Million - $2.45 Million
780,139 Added 5113.65%
795,395 $2.05 Million
Q2 2019

Aug 09, 2019

BUY
$2.53 - $3.04 $33,191 - $39,881
13,119 Added 613.9%
15,256 $46,000
Q1 2019

May 15, 2019

SELL
$2.51 - $3.73 $44,557 - $66,214
-17,752 Reduced 89.26%
2,137 $6,000
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $31,623 - $52,904
19,889 New
19,889 $47,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.